Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung Cancer
NCT00768755
ABOUT THIS STUDY
FOR MORE INFORMATION
Contact a representative by phone, email, or visiting the study website. Please see the references below:
Pfizer Clinical Trials Contact Center
1-800-718-1021
- Histologically or cytologically confirmed diagnosis of adeno-, large cell or bronchioalveolar non-small cell lung cancer
- Cytologic specimens for diagnosis or for cell type classification must have been obtained from bronchial brushings or washings or from needle aspiration of a defined lesion. Sputum cytology alone will not be acceptable for diagnosis or for cell type classification.
- Patients with mixed NSCLC with predominantly squamous cell carcinoma should be classified as squamous and thus do not qualify for this study.
- Stage IIIB with malignant effusion (with cytologic confirmation of malignant pleural or pericardial effusion), Stage IV, or recurrent disease after definitive loco-regional therapy.
- Candidate for primary treatment with cisplatin and pemetrexed
- Any histological/cytological evidence of predominantly squamous NSCLC.
- Small cell or carcinoid lung cancer patients are also ineligible.
- NSCLC that cannot be classified as one of the eligible histologies (adenocarcinoma,
large cell or bronchioalveolar).
- Prior systemic therapy for Stage IIIB (with malignant effusion), Stage IV, or
recurrent NSCLC. (Prior treatment with systemic therapy as adjuvant chemotherapy or in
conjunction with radiotherapy for Stage II or III NSCLC is permitted if the last dose
of chemotherapy was completed 12 months or more prior to randomization).
- Prior treatment with a VEGF or VEGFR inhibitor.
NEED INFO?
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
- Florence, Alabama
- Muscle Shoals, Alabama
- Scottsdale, Arizona
- Hot Springs, Arkansas
- Antioch, California
- Burbank, California
- Downey, California
- Fresno, California
- La Jolla, California
- La Jolla, California
- Montebello, California
- Pleasant Hill, California
- San Diego, California
- San Leandro, California
- Whittier, California
- Fairfield, Connecticut
- Brooksville, Florida
- Cocoa Beach, Florida
- Fort Lauderdale, Florida
- Merritt Island, Florida
- Rockledge, Florida
- Titusville, Florida
- Athens, Georgia
- Aurora, Illinois
- Goshen, Indiana
- Indianapolis, Indiana
- Council Bluffs, Iowa
- Baton Rouge, Louisiana
- Lafayette, Louisiana
- Bethesda, Maryland
- Ann Arbor, Michigan
- Troy, Michigan
- Columbus, Mississippi
- Corinth, Mississippi
- Tupelo, Mississippi
- St. Louis, Missouri
- St. Peters, Missouri
- Omaha, Nebraska
- Las Vegas, Nevada
- Las Vegas, Nevada
- Jamaica, New York
- Norman, Oklahoma
- Oklahoma City, Oklahoma
- Oklahoma City, Oklahoma
- Oklahoma City, Oklahoma
- Tulsa, Oklahoma
- Tulsa, Oklahoma
- Tulsa, Oklahoma
- Lancaster, Pennsylvania
- Knoxville, Tennessee
- Beaumont, Texas
- Dallas, Texas
- Grapevine, Texas
- Irving, Texas
- Bountiful, Utah
- Layton, Utah
- Murray, Utah
- Provo, Utah
- Salt Lake City, Utah
- Salt Lake City, Utah
- Sandy, Utah
- West Valley, Utah
- Kennewick, Washington
- Buenos Aires, Capital Federal
- Ciudad Autonoma de Buenos Aires, Capital Federal
- Buenos Aires,
- Cordoba,
- Grimmenstein,
- Innsbruck,
- Linz,
- Bruxelles,
- Leuven,
- Liege,
- Rio de Janeiro, RJ
- Rio de Janeiro, RJ
- Porto Alegre, RS
- Barretos, SP
- Sao Paulo, SP
- Kingston, Ontario
- Kingston, Ontario
- Oshawa, Ontario
- Toronto, Ontario
- Toronto, Ontario
- Greenfield Park, Quebec
- Levis, Quebec
- Rimouski, Quebec
- Saskatoon, Saskatchewan
- Quebec,
- Independencia, Santiago, RM
- Providencia, Santiago, RM
- Santiago,
- Medellin, Antioquia
- Medellin, Antioquia
- Ceske Budejovice,
- Nova Ves pod Plesi,
- Olomouc,
- Ostrava-Poruba,
- Praha 2,
- Praha 8,
- Pribram V,
- Tabor,
- Usti nad Labem,
- Herlev,
- Hilleroed,
- Koebenhavn OE,
- Odense,
- Bad Berka,
- Berlin,
- Dresden,
- Ebensfeld,
- Essen,
- Gauting,
- Grosshansdorf,
- Halle (Saale),
- Heidelberg,
- Homburg,
- Mainz,
- Tuebingen,
- Wiesbaden,
- Heraklion, Crete
- Alexandroupoli,
- Athens,
- Kifisia, Athens,
- Kowloon,
- Shatin, NT,
- Tuen Mun,,
- Budapest,
- Deszk,
- Gyula,
- Matrahaza,
- Szekesfehervar,
- Zalaegerszeg-Pozva,
- Catania,
- Grosseto,
- Mantova,
- Milano,
- Milano,
- Monza (MI),
- Novara,
- Orbassano (TO),
- Parma,
- Roma,
- Rozzano (MI),
- Seoul,
- Seoul,
- Seoul,
- Seoul,
- Enschede, Ov
- 's-Hertogenbosch,
- Amsterdam,
- Arnhem,
- Harderwijk,
- Maastricht,
- Rotterdam,
- Rotterdam,
- Kristiansand S,
- Oslo,
- Stavanger,
- Tromso,
- Trondheim,
- Lodz,
- Opole,
- Otwock,
- Warszawa,
- Warszawa,
- Zielona Gora,
- Moscow,
- Moscow,
- St-Petersburg,
- St. Petersburg,
- Bratislava,
- Kosice,
- Kvetnica pri Poprade,
- Nitra-Zobor,
- Zilina,
- Sabadell, Barcelona
- Palma de Mallorca, Islas Baleares
- La Laguna, Santa Cruz de Tenerife
- Dos Hermanas, Sevilla
- Barcelona,
- La Coruña,
- Madrid,
- Malaga,
- Sevilla,
- Valencia,
- Genolier,
- Gwei Shan Township, Taoyuan County
- Taichung,
- Tainan,
- Pathumwan, Bangkok
- Amphoe Mueang, Chiang Mai
- Bangkok,
- Bebington, Wirral,
- Cambridge,
- Derby,
- Dundee,
- Keighley, West Yorkshire,
- London,
- London,
- Peterborough,
- Rhyl, Denbigshire,
- Sheffield,
- Southampton,
- Yeovil, Somerset,
- Litchfield Park, Arizona
- Sun City, Arizona
- Bentonville, Arkansas
- Fayetteville, Arkansas
- Hudson, Florida
- New Port Richey, Florida
- Mahwah, New Jersey
- Midland Park, New Jersey
- Paramus, New Jersey
- Westwood, New Jersey
- Oneida, New York
- Oswego, New York
- Syracuse, New York
- Syracuse, New York
- Sylvania, Ohio
- Seattle, Washington
- Seattle, Washington
- Grosshansdorf,
- Mannheim,
- Torino,
- Tampa, Florida
- Park Ridge, Illinois
- Skokie, Illinois
- Louisville, Kentucky
- Louisville, Kentucky
- Houston, Texas
- Hamilton, Ontario
- Huntsville, Alabama
- Atlanta, Georgia
- Decatur, Georgia
- Macon, Georgia
- Marietta, Georgia
- Sandy Springs, Georgia
- Bloomington, Illinois
- Peoria, Illinois
- Hershey, Pennsylvania
- West Reading, Pennsylvania
- East Providence, Rhode Island
- East Providence, Rhode Island
- Genova,
- Lido di Camaiore (LU),
- Orbassano (TO),
- Sunto-gun, Shizuoka
- Lubin,
- Otwock,
- Pila,
- Poznan,
- Poznan,
- Prabuty,
- Warszawa,
- Bacau,
- Iasi,
- Moscow,
- Pyatigorsk,
- Saint-Petersburg,
- St.Petersburg,
- Terrassa, Barcelona
- Castellon,
- Madrid,
- Madrid,
- Palma de Mallorca,
- Sevilla,
- Basel,
- Basel,
- Bruderholz,
- Liestal,
- Taichung,
- Taichung,
- Taipei,
- Taipei,
- Dnipropetrovsk,
- Kyiv,
- Romford, Essex
- Northwood, Middlesex
- Bournemouth,
- Brighton,
- Dundee,
- Middlesex,
- Poole,
Descriptive Information | ||||
---|---|---|---|---|
Brief Title ICMJE | Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung Cancer | |||
Official Title ICMJE | Randomized Phase 2 Study Of Cisplatin/Pemetrexed With Or Without Axitinib (AG-013736) As First-Line Treatment For Patients With Non-Squamous Non-Small Cell Lung Cancer | |||
Brief Summary | AG-013736 (axitinib) in combination with cisplatin and pemetrexed will be evaluated as first-line treatment of patients with locally advanced, recurrent, or metastatic non-squamous, non small cell lung cancer (NSCLC). | |||
Detailed Description | Not Provided | |||
Study Type ICMJE | Interventional | |||
Study Phase ICMJE | Phase 1 Phase 2 | |||
Study Design ICMJE | Allocation: Randomized Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Treatment | |||
Condition ICMJE | Carcinoma, Non-Small Cell Lung | |||
Intervention ICMJE |
| |||
Study Arms ICMJE |
| |||
Publications * | Belani CP, Yamamoto N, Bondarenko IM, Poltoratskiy A, Novello S, Tang J, Bycott P, Niethammer AG, Ingrosso A, Kim S, Scagliotti GV. Randomized phase II study of pemetrexed/cisplatin with or without axitinib for non-squamous non-small-cell lung cancer. BMC Cancer. 2014 Apr 25;14:290. doi: 10.1186/1471-2407-14-290. | |||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. | ||||
Recruitment Information | ||||
Recruitment Status ICMJE | Completed | |||
Actual Enrollment ICMJE | 180 | |||
Original Estimated Enrollment ICMJE | 160 | |||
Actual Study Completion Date ICMJE | March 2012 | |||
Actual Primary Completion Date | March 2011 (Final data collection date for primary outcome measure) | |||
Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
| |||
Sex/Gender ICMJE |
| |||
Ages ICMJE | 18 Years and older (Adult, Older Adult) | |||
Accepts Healthy Volunteers ICMJE | No | |||
Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | |||
Listed Location Countries ICMJE | Italy, Japan, Poland, Romania, Russian Federation, Spain, Switzerland, Taiwan, Ukraine, United Kingdom, United States | |||
Removed Location Countries | South Africa | |||
Administrative Information | ||||
NCT Number ICMJE | NCT00768755 | |||
Other Study ID Numbers ICMJE | A4061039 | |||
Has Data Monitoring Committee | No | |||
U.S. FDA-regulated Product | Not Provided | |||
IPD Sharing Statement ICMJE | Not Provided | |||
Responsible Party | Pfizer | |||
Study Sponsor ICMJE | Pfizer | |||
Collaborators ICMJE | Not Provided | |||
Investigators ICMJE |
| |||
PRS Account | Pfizer | |||
Verification Date | October 2015 | |||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |